Jefferies initiates coverage of Thomson Reuters with buy rating and $130 target price
TRI•Jefferies initiated coverage of Thomson Reuters with a buy rating and a $130 target price.
Related News
Odyssey Therapeutics' OD-001 meets primary endpoint in Phase 2a ulcerative colitis trial
ODTX•
Xcel Energy: BMO cuts target price to $86 from $91
XEL•
Albemarle: Truist Securities cuts target price to $185 from $225
ALB•
UL Solutions publishes update to financial calendar
ULS•
CBRE agrees to buy Onnec for initial £460 million in cash
CBRE•